BeyondSpring (BYSI) Net Margin Growth (1y) (2021)
Powered by 
Analysis
BeyondSpring (BYSI) Net Margin Growth (1y) (2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | -146.00 |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 1,518.00 |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -3,607.00 |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -610.00 |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -2,157.00 |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | -3,647.00 |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 166.00 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 376.00 |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | - |